Mesenchymal stem cell-conditioned medium improved mitochondrial function and alleviated inflammation and apoptosis in non-alcoholic fatty liver disease by regulating SIRT1-Reference-Cited by-同舟云学术

Mesenchymal stem cell-conditioned medium improved mitochondrial function and alleviated inflammation and apoptosis in non-alcoholic fatty liver disease by regulating SIRT1

Published:2021-03 Issue: Volume:546 Page:74-82
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Yang Mengmeng,Cui Yixin,Song Jia,Cui Chen,Wang Lingshu,Liang Kai,Wang Chuan,Sha Sha,He Qin,Hu Huiqing,Guo Xinghong,Zang Nan,Sun Lei,Chen Li

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference29 articles.

1. Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study;Williamson;Diabetes Care,2011

2. Prevalence of non-alcoholic fatty liver disease in four different weight related patient groups: association with small bowel length and risk factors;Hillenbrand;BMC Res. Notes,2015

3. Nonalcoholic fatty liver disease in patients with type 2 diabetes;Younossi;Clin. Gastroenterol. Hepatol.,2004

4. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease;Hossain;Clin. Gastroenterol. Hepatol.,2009

5. Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications;Castro-Manrreza;J Immunol Res,2015

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ginsenoside Rg1 alleviates diabetic liver injury and fibrosis by inhibiting the PLC-NFAT2-NLRP3 signaling pathway in T2DM mice;Journal of Functional Foods;2024-10

2. Mesenchymal stem cell-conditioned medium prevents inflammation-induced liver and lung damage in septic mice;International Immunopharmacology;2024-08

3. Current perspectives on mesenchymal stem cells as a potential therapeutic strategy for non-alcoholic fatty liver disease;World Journal of Stem Cells;2024-07-26

4. Mesenchymal stromal cells ameliorate mitochondrial dysfunction in α cells and hyperglucagonemia in type 2 diabetes via SIRT1/FoxO3a signaling;Stem Cells Translational Medicine;2024-06-12

5. Controlled release of hydrogel-encapsulated adipose-derived mesenchymal stem cells-conditioned medium promotes functional liver regeneration after partial hepatectomy in a rodent model of metabolic dysfunction-associated steatotic liver disease;2024-06-06